BIIB
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China
Tuesday, January 9, 2024 1 min read
Key Takeaway: “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China
Full Press Release Details
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China.